Accuray Incorporated is a radiation therapy company that develops, manufactures, sells, and supports solutions for complex radiation treatments. Co.'s technologies, including the CyberKnife and TomoTherapy platforms (like the Radixact System), enhance patient care throughout the cancer treatment journey, from curative to palliative treatments. These platforms offer advanced treatments such as stereotactic radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy. Co. also provides post-contract customer support, installation, training, and other professional services. The ARAY YTD return is shown above.
The YTD Return on the ARAY YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether ARAY YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the ARAY YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|